Goodrx Holdings Inc (GDRX) — Capital Reinvestment Ratio
Latest as of September 2025:
0.24x
Goodrx Holdings Inc (GDRX) has a Capital Reinvestment Ratio of 0.24x as of September 2025, meaning it reinvests 0% of its operating cash flow ($76.02 Million) in capital expenditures ($18.00 Million). See free cash flow generation of Goodrx Holdings Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.24x
Capex / Operating Cash Flow
Operating Cash Flow
$76.02 Million
USD
Capital Expenditures
$18.00 Million
USD
Data as of
Sep 2025
Most recent filing
Goodrx Holdings Inc Capital Reinvestment Ratio (2018–2024)
This chart tracks Goodrx Holdings Inc's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for Goodrx Holdings Inc (2018–2024)
Year-by-year Capital Reinvestment Ratio for Goodrx Holdings Inc from 2018 to 2024. For live market cap and broader valuation context, see Goodrx Holdings Inc (GDRX) total market value.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | $183.89 Million | $70.35 Million | ▼ -5.1% |
| 2023 | 0.40x | $138.29 Million | $55.77 Million | ▲ +7.2% |
| 2022 | 0.38x | $146.78 Million | $55.21 Million | ▲ +95.2% |
| 2021 | 0.19x | $178.78 Million | $34.46 Million | ▼ -29.3% |
| 2020 | 0.27x | $131.34 Million | $35.82 Million | ▲ +295.1% |
| 2019 | 0.07x | $83.29 Million | $5.75 Million | ▼ -9.7% |
| 2018 | 0.08x | $45.25 Million | $3.46 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow